Here is a story about two individuals, Michael Hurst and Sandy Bishop, who both experienced positive impacts from fecal transplants. While we do not endorse do it yourself methods and recognize that more research is needed regarding the effectiveness of fecal transplants for conditions other than the treatment of Clostridium […]

PUNCH™ CD 2 Study: A Clinical Trial For The Treatment Of Recurrent Clostridium difficile Infection Is Currently Enrolling Patients     The PUNCH™ CD 2 study, sponsored by Rebiotix Inc., is open for enrollment and actively recruiting patients. This study represents Rebiotix progress toward developing and commercializing a new therapy […]

Statistically Significant Positive Results from First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes– –NM504 Significantly Improved Glucose Control in Patients with Prediabetes and Type 2 Diabetes– PR Newswire BROOMFIELD, Colo., Feb. 18, 2014 BROOMFIELD, Colo., Feb. 18, 2014 /PRNewswire/ — MicroBiome Therapeutics™ LLC, (MBT) today announced positive […]

After the success of the first two editions (held in Evian and Madrid in 2012 and 2013 respectively),experts from all over the world are getting ready to head to Miami (USA) for the 2014 edition of the Gut Microbiota for Health World Summit, to be held on 8 and 9 March. For two days, scientists […]

The Taymount Clinic was founded by Glenn Taylor and Enid Learmount (now Enid Taylor ND) in 2003 as a small private clinic specializing in digestive health. Initially the clinic focused on Naturopathic Medicine and its relationship to food so there were seminars, consultations and workshops to educate people about diet, […]

This is the first multi-center study of a next-generation fecal transplant. The PUNCH™ CD study, sponsored by Rebiotix Inc., has completed enrollment. This study represents Rebiotix’s progress toward developing and commercializing a new non-antibiotic, therapy to treat patients with recurrent episodes of debilitating and potentially life-threatening Clostridium difficile infection (CDI). […]

Taymount Clinic located in the U.K., is selling tested donor stool to physicians and hospitals in the U.K. and Europe.

I would like to announce what will be an ongoing relationship between The Foundation, and Open Biome, a brilliant and compassionate group of scientists from MIT, Harvard, and Princeton, who have formed a 501c(3) to develop a donor stool bank which provides tested, frozen, and ready to use donor stool […]

A huge thank you to the Peggy Lillis Memorial Foundation, who had me as their guest speaker this year at the 4th Annual Fight C. diff. Gala, in NY on October 18. I was so honored to be present to see Congresswoman Louise Slaughter (D-NY) receive the Lifetime Achievement Award for […]

Thank you to the wonderful people at the DelMarva Foundation who had me as their guest speaker at their Fight C. diff. Conference on Thursday, September 26th, in Baltimore, MD. They are so excited and motivated in the continuing efforts to prevent C. diff. in healthcare facilities in their tri-state […]

The IDSA, ASGE, NASPGHAN, AGA & ACG have agreed on a protocol for donor screening and stool testing. Read more…